English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
Doubleview Provides Cobalt Resource Summary for the Hat Polymetallic Deposit in Advance of Updated MRE and PEA
Dec 02, 2025 21:59 HKT
Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks
Dec 02, 2025 21:55 HKT
OpenAI Joins the Global Anti-Scam Alliance as Foundation Member to Strengthen Global Response Against AI-Enabled Scams
Dec 02, 2025 21:00 HKT
Digital Realty and BW Digital Partner to Support Expansion of Cross-Border Connectivity Between Singapore and Batam
Dec 02, 2025 15:49 HKT
GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Dec 02, 2025 13:00 HKT
AdipoLABs Opens New Regional Office, Signs Two MoUs With University of Cyberjaya to Advance Healthcare Innovation
Dec 02, 2025 12:22 HKT
Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms
Dec 01, 2025 22:04 HKT
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
Dec 01, 2025 21:43 HKT
GMG Launches Pre-Order Sales for First to Market Multi Language THERMAL-XR(R) Kit with Electric Spray Gun
Dec 01, 2025 21:29 HKT
Fujitsu launches 'Fujitsu Accelerator Program for SPORTS' to create new value through Sports x Technology
Dec 01, 2025 21:14 HKT
HashKey Passes HKEX Hearing: From Asia's Compliance Pioneer to a Global Institutional Gateway for Digital Assets
Dec 01, 2025 18:39 HKT
AcroMeta Announces Strategic Joint Venture to provide AI-Powered Global Trade Operating System
Dec 01, 2025 18:20 HKT
FG Gold, AFC and Afreximbank Reach Financial Close on US$330 Million Senior Debt Financing for Baomahun Gold Project
Dec 01, 2025 17:09 HKT
China Chunlai Announces 2025 Annual Results
Dec 01, 2025 09:53 HKT
USDKG launching: $50M Gold-backed Stablecoin in the Kyrgyz Republic
Nov 29, 2025 23:00 HKT
Eisai Submits New Drug Application for Subcutaneous Formulation of "LEQEMBI(R)" for the Treatment of Early Alzheimer's Disease in Japan
Nov 28, 2025 22:00 HKT
Capital Revo Expands Trader Education Framework Amid Rising 2025 User Engagement
Nov 28, 2025 22:00 HKT
Eternal Beauty Holdings Announces First Results Since Listing, Interim Profit for FY2025/2026 Increased 15.3% YoY to RMB 1.3 Million
Nov 28, 2025 20:12 HKT
JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information
Nov 28, 2025 18:41 HKT
MHI Publishes "MHI REPORT 2025" and "SUSTAINABILITY DATABOOK 2025"
Nov 28, 2025 18:05 HKT
<< Previous Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: